Literature DB >> 2892104

Pharmacological characterisation of the dopamine-sensitive adenylate cyclase in cockroach brain: evidence for a distinct dopamine receptor.

G L Orr1, J W Gole, H J Notman, R G Downer.   

Abstract

Dopamine increases cyclic AMP production in crude membrane preparations of cockroach brain with plateaus in cyclic AMP production occurring between 1-10 microM and at 10 mM. Maximal production of cyclic AMP is 2.25 fold greater than that of control values. Octopamine also increases cyclic AMP production with a Ka of 1.4 microM and maximal production 3.5 fold greater than that of control. 5-Hydroxytryptamine does not increase cyclic AMP production. The effects of octopamine and dopamine are fully additive. The vertebrate dopamine agonists ADTN and epinine stimulate the dopamine-sensitive adenylate cyclase (AC) with Ka values of 4.5 and 0.6 microM respectively and with maximal effectiveness 1.7 fold greater than that of control. The selective D2-dopamine agonist LY-171555 stimulates cyclic AMP production to a similar extent with a Ka of 50 microM. Other dopamine agonists (apomorphine, SKF-82526, SKF-38393) have no stimulatory effects. The octopamine-sensitive AC is inhibited by a variety of antagonists known to affect octopamine and dopamine receptors, with the following order of potency: mianserin greater than phentolamine greater than cyproheptadine greater than piflutixol greater than cis-flupentixol greater than SCH-23390 greater than (+)-butaclamol greater than SKF-83566 greater than SCH-23388 greater than sulpiride greater than spiperone greater than haloperidol. The dopamine-sensitive AC is inhibited by the same compounds with the following order of potency: piflutixol greater than cis-flupentixol greater than (+)-butaclamol greater than spiperone greater than or equal to SCH-23390 greater than cyproheptadine greater than SKF-83566 greater than SCH 23388 greater than mianserin greater than phentolamine greater than sulpiride greater than haloperidol. With the exception of mianserin, 3H-piflutixol is displaced from brain membranes by dopamine antagonists with an order of potency similar to that observed for the inhibition of dopamine-sensitive AC. The results indicate that the octopamine- and dopamine-sensitive AC in cockroach brain can be distinguished pharmacologically and the dopamine receptors coupled to AC have pharmacological characteristics distinct from vertebrate D1- and D2-dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892104     DOI: 10.1016/0024-3205(87)90463-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists.

Authors:  V Reale; F Hannan; L M Hall; P D Evans
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

3.  Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster.

Authors:  G Feng; F Hannan; V Reale; Y Y Hon; C T Kousky; P D Evans; L M Hall
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

4.  Olfactory modulation by dopamine in the context of aversive learning.

Authors:  Andrew M Dacks; Jeffrey A Riffell; Joshua P Martin; Stephanie L Gage; Alan J Nighorn
Journal:  J Neurophysiol       Date:  2012-05-02       Impact factor: 2.714

5.  Aminergic neurons in the brain of blowflies and Drosophila: dopamine- and tyrosine hydroxylase-immunoreactive neurons and their relationship with putative histaminergic neurons.

Authors:  D R Nässel; K Elekes
Journal:  Cell Tissue Res       Date:  1992-01       Impact factor: 5.249

6.  Characterization of an invertebrate-type dopamine receptor of the American cockroach, Periplaneta americana.

Authors:  Britta Troppmann; Sabine Balfanz; Christian Krach; Arnd Baumann; Wolfgang Blenau
Journal:  Int J Mol Sci       Date:  2014-01-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.